We are live on
!
Find out more
EMFAT
Emerald Mutual Fund Advisers Trust Portfolio holdings
AUM
$2.06B
1-Year Est. Return
106.87%
This Fund
S&P 500
This Quarter
Est. Return
+10.15%
1 Year Est. Return
+106.87%
3 Year Est. Return
+347.49%
5 Year Est. Return
+440.43%
10 Year Est. Return
+3,482.63%
AUM
$1.69B
AUM Growth
+$78.1M
(+4.8%)
Cap. Flow
+$16.4M
Cap. Flow
% of AUM
0.97%
Top 10 Holdings %
Top 10 Hldgs %
18.04%
Holding
278
New
59
Increased
69
Reduced
68
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$15.2M |
| 2 |
Tenable Holdings
TENB
|
+$14.5M |
| 3 |
Fabrinet
FN
|
+$11.4M |
| 4 |
LivaNova
LIVN
|
+$11.3M |
| 5 |
ICU Medical
ICUI
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProFrac Holding
ACDC
|
+$20.5M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$15.9M |
| 3 |
Customers Bancorp
CUBI
|
+$13.9M |
| 4 |
MACOM Technology Solutions
MTSI
|
+$11.3M |
| 5 |
PRFT
Perficient Inc
PRFT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.48% |
| 2 | Technology | 15.58% |
| 3 | Industrials | 15.3% |
| 4 | Consumer Discretionary | 13.22% |
| 5 | Financials | 9.83% |
Similar funds
BMCM
GIM
WFMPM
HBT
BC
SW
RC
AG
Emerald Mutual Fund Advisers Trust's Q1 2023 Portfolio in Review
As of Q1 2023, Emerald Mutual Fund Advisers Trust held 278 positions worth $1.69B, up 4.8% from $1.61B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Emerald Mutual Fund Advisers Trust's Q1 2023 filing shows 59 new, 69 increased, 68 reduced and 61 closed positions. Its largest new stake was Fabrinet: 92,046 shares worth $10.9M. The largest sale was ProFrac Holding, an estimated $20.5M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.
- Emerald Mutual Fund Advisers Trust's largest Q1 2023 buy was Fabrinet: 92,046 shares worth $10.9M.
- Emerald Mutual Fund Advisers Trust added most to Madrigal Pharmaceuticals in Q1 2023, an estimated $15.2M increase.
- Emerald Mutual Fund Advisers Trust's biggest Q1 2023 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $15.9M.
- Emerald Mutual Fund Advisers Trust fully exited ProFrac Holding in Q1 2023, selling an estimated $20.5M.
- Emerald Mutual Fund Advisers Trust's ten largest holdings make up 18% of its $1.69B portfolio in Q1 2023.
- Emerald Mutual Fund Advisers Trust opened 59 new positions and closed 61 in Q1 2023.
- Emerald Mutual Fund Advisers Trust's portfolio value rose 4.8% quarter-over-quarter to $1.69B.
Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2023, filed 4 May 2023.